Programme: BIochemistry

Permanent URI for this collectionhttp://itsupport.cu.edu.ng:4000/handle/123456789/28779

Here you will find works strictly related to Biochemistry

Browse

Start date: 2025

Search Results

Now showing 1 - 10 of 64
  • No Thumbnail Available
    Item
    GC–MS analysis of locally processed palm kernel oil and its mild ameliorative effects on carbon tetrachloride-induced toxicity in rats
    (Comparative Clinical Pathology, 2025-11) Ugbogu, Eziuche A.; Iweala, Emeka J.; Jessie‑Green, Gina; Amuji, Doris Nnenna; Nwankwo, Nnamdi; Okoro, Benedict Chukwuebuka; Dania, Omoremime Elizabeth
    This study investigated the phytochemical composition of locally processed palm kernel oil (LPPKO) and its ameliorative effect on carbon tetrachloride ( CCl4) toxicity in albino Wistar rats. Phytochemical composition was analysed by gas chromatography–mass spectrometry (GC–MS). For acute toxicity, a single oral dose of up to 5000 mg/kg LPPKO was administered. On day 1, groups 2–5 experimental rats received a single dose of 1 mL/kg CCl4 diluted 1:1 in olive oil. Thirty minutes after CCl4 administration, rats in groups 3, 4, and 5 received LPPKO orally at 100, 200, and 300 mg/kg body weight, respectively, for 14 days. GC–MS analysis identified nine bioactive compounds with pharmacological properties, including 9,12-octadecadienoic acid (Z,Z) and β-sitosterol. The acute toxicity assessment revealed no detectable signs of toxicity or mortality. The results showed a significant (P < 0.05) increase in high-density lipoproteins, superoxide dismutase (SOD), glutathione (GSH), and catalase (CAT) and a significant (P < 0.05) decrease in aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), urea, total cholesterol, platelets, chloride, and malondialdehyde (MDA) in the LPPKO-treated groups compared to the CCl4- induced untreated groups (negative control) in both male and female rats. LPPKO treatment has a positive effect on CCl4- induced toxicity in rats by decreasing ALT, AST, ALP, and MDA and increasing SOD, GSH, and CAT. This study shows that LPPKO has the potential to mildly reduce the toxic effect of CCl4 on the liver of Wistar rats.
  • No Thumbnail Available
    Item
    Overview of the human genome
    (Translational and Applied Genomics, 2025) Oyelade, Jelili; Isewon, Itunuoluwa; Ogunlana, Olubanke; worunse, Oluwadurotimi A; Oyesola, Olusola; Aromolaran, Olufemi; Dokumu, Titilope; \uwagun, Ibitayo Adem; Iheagwam, Franklyn; Babatunde, Eunice; Dania, Omoremime Elizabeth; Obembe, Olawole
    The human genome is composed of deoxyribonucleic acid (DNA) organized into 23 pairs of chromosomes in the nucleus of human cells, as well as the small DNA found inside individual mitochondria. Complete sequencing of the 3 billion base pairs that make up the human genome has made available a deluge of information that has enhanced our understanding of evolution, physiology, causality of disease, and association between heredity and environment in humans. This chapter discusses discoveries in genetics that spawned the field of human genomics. It further highlights the role of human genome in disease susceptibility, as well as its prospects for the future of healthcare.
  • No Thumbnail Available
    Item
    Corrigendum to “Phytochemical composition, acute and subacute toxicity profile of Persea amaricana seed oil in albino Wistar rats” [Toxicol. Rep. 14 (2025) 101982]
    (Toxicology Reports (Elsevier), 2025) Iweala, Emeka J.; Okore, Finian Uchenna; Okoro, Benedict Chukwuebuka; Dania, Omoremime Elizabeth; Amuji, Doris Nnenna; Ugbogu, Eziuche A.
  • No Thumbnail Available
    Item
    Ethnopharmacological relevance, phytochemistry, potential health benefits and toxicity profile of Ananas comosus (L.) Merr (pineapple)
    (Pharmacological Research - Natural Products 10 ( Elsevier), 2026) Ugbogu, Eziuche A.; Iweala, Emeka Joshua; Ukachukwu, Chukwudi Eke; Babayo, Christy; Dania, Omoremime Elizabeth; Isreal, Chollom Longs; Omonhinmin, Conrad A.; Cleanclay, Wisdom D.; Okoro, Benedict Chukwuebuka
    In traditional medicine, the cortexes of A. comosus are used as an alexipharmic, antitussive, and antidiarrheal agent, while the leaves are commonly used as a remedy for indigestion. This review provides a thorough and upto- date literature on the ethnopharmacological uses, phytochemistry, and potential health benefits of A. comosus. The articles used for this study were obtained from databases such as ScienceDirect, Frontiersin, PubMed, Springer, and MDPI. In addition, only articles written in English were included in this review. Phytochemical analysis revealed that A. comosus contains numerous biologically active compounds, including n-hexadecanoic acid, bromelain, n-heptadecanol-1, methyl ester, hexadecanoic acid, squalene, α-tocopherol, tetradecane, 5- hydroxymethylfurfural, dihydroxyacetone, dodecane, DL-α-tocopherol, furan methanol, dodecanoic acid, and 2,4,6-cycloheptatrien-1-one, among others. Various in vivo and in vitro biochemical studies have also shown that A. comosus possesses antioxidant, anti-inflammatory, anticancer, antidiarrheal, antimicrobial, antimalarial, cardioprotective, anthelmintic, and antidiabetic properties. Therefore, this review shows the biologically active compounds in A. comosus and the potential of different parts of A. comosus to prevent and treat various diseases. While A. comosus has shown promise in animal studies, human clinical trials are needed to determine safe and effective doses. Further research may reveal additional uses for this versatile plant as a functional food and in modern healthcare as a traditional and complementary alternative medicine.
  • No Thumbnail Available
    Item
    Abstract 999: Spectrum of germline BRCA1/2 gene mutations in Nigerian breast cancer patients
    (Cancer Res (2025) 85 (8_Supplement_1):, 2025-04-21) Onyia, Abimbola F.; Jibrin, Paul; Olatunji-Agunbiade, Temitope; Oyekan, Ademola; Lawal, AbdulRazzaq; Alabi, Adewumi; Sowunmi, Anthonia C.; Aje, Eben A.; Ogunniyi, Oluwabusayo B.; Nkom, Ebenezer S.; De Campos, Opeyemi C.; Rotimi, Oluwakemi A.; Oyelade, Jelili O.; Rotimi, Solomon O.
    Breast cancer (BC) is the leading cause of cancer-related deaths in Nigerian women, with triple-negative breast cancer (TNBC) being the most prevalent. The TNBC subtype is characterized by mutations in BRCA1 and BRCA2 genes, and germline pathogenic carriers of these mutations have an increased risk for BC. Despite these challenges, the prevalence and spectrum of BRCA1/2 pathogenic variants in the Nigerian population differ, and there is a margin in the local capacity to characterize these variations. Therefore, this study aimed to identify and characterize germline variations in BRCA 1/2 genes in Nigerian BC patients and healthy aged-matched controls to understand the genetic risk profiles of BC in this population. Forty-five BC patients were recruited across four major hospitals in Nigeria and aged-matched with 51 healthy female controls. DNA was extracted from blood samples, followed by targeted sequencing of BRCA 1/2 intronic and exonic regions using the Ampliseq for BRCA panel and the Illumina Miseq Platform. Variant calling was performed, and the clinical significance of identified variants was evaluated on the ClinVar and BRCA exchange databases. Variants of unknown significance (VUS) were assessed using known in silico prediction software, and haplotype analysis was carried out using the Haploview 4.2 software. Pathogenic variants were identified in 6.7% of cases, all exclusive to BC patients. These variants included two BRCA1 variants (3: c.133_134delAA (p.Lys45fs) and c.5324T>A (21: p.Met1775Lys), and one BRCA 2 variant (22: c.8817_8820del (p.Lys2939fs) all found in patients with the TNBC subtype. Additionally, 97 benign or likely benign BRCA1/2 variants were found in both BC and control groups, with notable variants such as the rs799917 identified as a surrogate indicator of ancestry. Eighteen VUS were identified, with four predicted to be damaging by three in silico prediction software. The results of haplotype analysis identified distinct BC haplotypes in Nigerian BC patients. The identification of BRCA1/2 pathogenic variants in Nigerian BC patients, especially those with TNBC, suggests a potential for targeted therapies, such as PARP inhibitors, to improve treatment outcomes in this population. This further highlights the need for increased population-specific screening and the integration of genetic screening into BC management strategies, which could facilitate early detection, personalized treatment plans, and genetic counseling for Nigerian BC patients.
  • No Thumbnail Available
    Item
    Surveillance of Wolbachia infection in mosquito species in Ota, Ogun State, Nigeria
    (Discover Applied Sciences, 2025-03-27) Tebamifor, Mercy Eyitomi; Cleanclay, Wisdom D.; Mamudu, Collins Ojonugwa; Ogunlana, Olubanke Olujoke
    Introduction In light of climate change, proliferation of mosquito-borne diseases like dengue and malaria is a mounting concern, driven by expanding mosquito populations as a result of favorable environment for their survival. Addressing public health challenges caused by mosquitoes demands constant innovation and sustainable solutions. Objective This study responds to recent reports of Wolbachia infections in West African mosquito species, suggesting their potential as biocontrol agents for disease vectors. We seek to detect the presence of Wolbachia pipientis in different mosquito species in Ota and identify mosquito species present in the area. Method We conducted a comprehensive mosquito larval surveillance in Ota, Ogun State, Nigeria using a systematic stratified random sampling method from November 2022 to March 2023 to assess mosquito species distribution and Wolbachia infection. During this period, we surveyed mosquito larvae in various sites, rearing them to adulthood. We meticulously identified species, sex, and collection locations then, stored specimens at − 20 °C. Sodium chloride precipitation protocol was employed to extract DNA from the mosquitoes individually. Polymerase chain reaction (PCR) analysis was carried out using one to one point five microliter of DNA, with distilled water as negative control. Results Out of 1265 emerging young adult mosquitoes, 62.1% were females, while 37.1% were males. Aedes species constituted 22.2%, Anopheles 37.2%, and Culex 40.6% of the population. DNA analysis identified Wolbachia infection in Ae. albopictus and Ae. aegypti, with wsp gene sizes ranging from 590 to 632 bp, confirming Wolbachia presence by sequencing. Conclusion Our study is the first report on Wolbachia presence in Aedes sp within this region, which suggests that this mosquito species is a less likely vector for dengue virus and other related infectious agents. The study highlights the importance of continuous mosquito population and breeding site monitoring for potential biocontrol interventions against disease vectors.
  • No Thumbnail Available
    Item
    Targeting invasion-associated proteins PfSUB2 and PfTRAMP in Plasmodium falciparum: identification of potential inhibitors via molecular docking
    (BMC Infectious Diseases, 2025) Okafor, Esther. O.; Bella-Omunagbe, Mercy; Elugbadebo, Temitope; Dokunmu, Titilope M.; Adebiyi, Ezekiel
    Plasmodium falciparum subtilisin-like protease 2 (PfSUB2) is responsible for processing Plasmodium falciparum thrombospondin-related apical merozoite protein (PfTRAMP). These proteins are essential for asexual blood stage growth and RBC invasion and have, therefore, been identified as potential drug targets. This study predicted the three-dimensional structure of PfSUB2 and PfTRAMP and identified potential inhibitors using molecular docking methods. Five hundred nineteen compounds were docked against both proteins with AutoDock Vina in PyRx. Compounds 139,974,934 and 154,414,021 exhibited better binding affinities when compared to the standard inhibitors, PMSF, which highlights them as suitable inhibitors and potential antimalarials targeting PfTRAMP and PfSUB2. It also highlights 155,204,487 as a compound with dual antimalarial target potential, exhibiting a better binding affinity to PfTRAMP and PfSUB2. The study recommends 139,974,934, 154,414,021, and 155,204,487 as possible compounds for antimalarial drug development.
  • No Thumbnail Available
    Item
    Mechanisms of carbamate resistance in the malaria vector: Anopheles gambiae
    (Parasite Epidemiology and Control, 2026-02-18) Cleanclay, Wisdom D.; Akanni, Mosunmola H.; Bajepade, Tobiloba I.; Ajeoge, Joshua K.; Zakari, Suleiman
    In Africa, the female Anopheles gambiae is the primary malaria vector and a key target of vector control measures. The four principal classes of insecticides used in the control of these vectors are pyrethroids, organophosphates, carbamates and organochlorines. Historically, pyrethroids were the main type of insecticides employed to impregnate insecticide-treated nets because they are less toxic to humans and more effective against mosquitoes. The effectiveness of these interventions is however currently challenged by the development of pyrethroid-resistant mosquito populations. The World Health Organization recommends alternative or rotational use of carbamate insecticides in pyrethroid resistant areas. The mechanism of action of carbamates is to inhibit acetylcholinesterase reversibly to trigger the build-up of acetylcholine in mosquito nerves and consequent paralysis and death of the mosquito. However, carbamate resistance is also on the rise, and poses significant issues to malaria control systems. Notably, the mechanisms of carbamate resistance in Anopheles gambiae are target site mutations in the acetylcholinesterase gene and increased detoxification of carbamate by enzymes, including esterases and cytochrome P450s. This review presents a synthesis of existing information on the molecular and metabolic pathways of carbamate resistance in the Anopheles gambiae and discuss their consequences for the control of malaria vector. Understanding these resistance mechanisms is crucial for sustaining the effectiveness of IRS, informing insecticide resistance management strategies, and guiding malaria control policies in areas where pyrethroid resistance is increasing. AnophelesAnophelesAnophelesKeywords: Carbamate, Insecticide Resistance, female Anopheles gambiae, Malaria Vector
  • No Thumbnail Available
    Item
    Ex Vivo Molecular Studies and In Silico Small Molecule Inhibition of Plasmodium falciparum Bromodomain Protein 1
    (Drugs Drug Candidates, 2025-06-22) Oladejo, David O.; Dokunmu, Titilope M.; Oduselu, Gbolahan O.; Oladejo, Daniel O.; Ogunlana, Olubanke O.; Iweala, Emeka E. J.
    Background: Malaria remains a significant global health burden, particularly in sub- Saharan Africa, accounting for high rates of illness and death. The growing resistance to frontline antimalarial therapies underscores the urgent need for novel drug targets and therapeutics. Bromodomain-containing proteins, which regulate gene expression through chromatin remodeling, have gained attention as potential targets. Plasmodium falciparum bromodomain protein 1 (Pf BDP1), a 55 kDa nuclear protein, plays a key role in recognizing acetylated lysine residues and facilitating transcription during parasite development. Methods: This study investigated ex vivo PfBDP1 gene mutations and identified potential small molecule inhibitors using computational approaches. Malariapositive blood samples were collected. Genomic DNA was extracted, assessed for quality, and amplified using Pf BDP1-specific primers. DNA sequencing and alignment were performed to determine single-nucleotide polymorphism (SNP). Structural modeling used the PfBDP1 crystal structure (PDB ID: 7M97), and active site identification was conducted using CASTp 3.0. Virtual screening and pharmacophore modeling were performed using Pharmit and AutoDock Vina, followed by ADME/toxicity evaluations with SwissADME, OSIRIS, and Discovery Studio. GROMACS was used for 100 ns molecular dynamics simulations. Results: The malaria prevalence rate stood at 12.24%, and the sample size was 165. Sequencing results revealed conserved PfBDP1 gene sequences compared to the 3D7 reference strain. Virtual screening identified nine lead compounds with binding affinities ranging from −9.8 to −10.7 kcal/mol. Of these, CHEMBL2216838 had a binding affinity of −9.9 kcal/mol, with post-screening predictions of favorable drug-likeness (8.60), a high drug score (0.78), superior pharmacokinetics, and a low toxicity profile compared to chloroquine. Molecular dynamics simulations confirmed its stable interaction within the PfBDP1 active site. Conclusions: Overall, this study makes a significant contribution to the ongoing search for novel antimalarial drug targets by providing both molecular and computational evidence for PfBDP1 as a promising therapeutic target. The prediction of CHEMBL2216838 as a lead compound with favorable binding affinity, drug-likeness, and safety profile, surpassing those of existing drugs like chloroquine, sets the stage for preclinical validation and further structure-based drug design efforts. These findings are supported by prior experimental evidence showing significant parasite inhibition and gene suppression capability of predicted hits.
  • No Thumbnail Available
    Item
    Age-specific patterns of breast cancer in Nigerian women unraveled through histological analysis
    (Scientific Reports, 2025) Effiong, Magdalene Eno; Chinedu, Shalom Nwodo; Afolabi, Israel Sunmola; Ezike, Kevin Nwabueze; Oguntebi, Emmanuel Eyitayo; Abdul, Oluwasesan Adelowo; Achusi, Izuchukwu Benerdin; Benye, Tolulope Aanuoluwapo; Omunagbe, Mercy Bella; Ogbodo, Peace Nzubechukwu
    Sub-Saharan African women face a high burden of breast cancer, influenced by genetic and lifestyle factors. However, the lack of comprehensive, age-stratified data hinders the identification of risk factors and the development of effective, population-specific interventions. This study aimed to assess age-related variations in breast cancer prevalence among Nigerian women, providing insight into associated risk factors and disease trends. A retrospective review of 3,263 breast histopathology records (9.46% of total from 2015 to 2023) was conducted. Lesions—benign and malignant—were analyzed across five age groups: children and adolescents (0–19), young adults (20–39), middle-aged (40–59), higher-aged (60–79), and elderly (≥ 80), using MS Excel and GraphPad Prism 8.0. Statistical comparisons were performed by age and lesion type. Most cases were in young adults (45.97%) and middle-aged women (33.83%). The left breast was more commonly affected (46.86%) and had higher malignancy rates than the right (44.41%) or bilateral lesions (7.20%). Benign lesions were predominant (56.76%), especially among young adults (57.34%). Malignancy incidence increased with age, peaking in middle-aged women (53.30%). Fibroadenoma was the most frequent benign lesion in children and adolescents and young adults, while fibrosis predominated in middle age. Invasive ductal carcinoma (IDC) was the leading malignant subtype, with a sharp rise by 2023—particularly among middle-aged (172 cases) and young adult women (71 cases). Among 339 immunohistochemically profiled cases, triple-negative breast cancer (TNBC; 42.77%) and ER+/PR+ tumors (36.87%) were most common. TNBC was the only subtype detected in children and adolescents. Middle-aged women bore the highest burden of all subtypes, with a marked increase in TNBC and ER+/PR+ cases in 2023. The rising incidence of aggressive subtypes, particularly TNBC, highlights the need for enhanced molecular diagnostics and personalized therapies. Age-specific trends reinforce the urgency for targeted screening, especially for young and middle-aged Nigerian women.